The inhibition of HIF-1α activity was proposed as a promising cancer treatment strategy [26], either by inhibiting PDK1 activity using a specific inhibitor or knocking down LDHA by siRNA to slow tumor growth [27, 28], indicating that certain HIF-1α-responsive genes that are associated with energy metabolism could be potential candidates for cancer therapy. The gene discussed is PDK1; the disease is cancer.